MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Prevalence of Advanced Parkinson’s Disease and Potential Candidacy for Device-Aided Therapies in the Casablanca Region: Preliminary Results of a Multicenter Regional Study

    M. Daghi, A. Lakhdar, H. El Otmani (Casablanca, Morocco)

    Objective: This preliminary study aims to investigate the prevalence of advanced Parkinson's disease (PD) among patients receiving treatment in the Casablanca region of Morocco. Background:…
  • 2024 International Congress

    No Association between Anemia and Risk of Parkinson’s Disease: Evidence From A Meta-Analysis Using Real-World Evidence

    S. Zayed, S. Tabassum (Ranchi, India)

    Objective: To explore the association between anemia and the risk of Parkinson’s disease. Background: Parkinson’s disease (PD) is a common progressive neurodegenerative neurological disorder. More than…
  • 2024 International Congress

    Depressive Symptomatology and Neuropsychiatric Profile in Patients with Idiopathic Parkinson’s Disease without Dementia (IPDWD). Preliminary Data from a New Scale Specifically for Measuring Depression in Patients with IPDWD.

    C A. Hurtado-Gonzalez, J F. Ayala-Rico, S. Ospina-Otalvaro, J M. Márquez, L. Ortega-Bolaños, D A. Reyes-Torres, P A. Gutiérrez-Lenis, L M. Saldarriaga, C O. Moreno (Cali, Colombia)

    Objective: : To identify whether depression in patients with IPDWD correlates with different types of behavioral symptoms. Background: Depression is considered a frequent neuropsychiatric pathology…
  • 2024 International Congress

    Exploring the Feasibility of Telerehabilitation for Balance Deficits in People with PD; the TelePD Trial

    L. King, C. Silva-Batista, J. Wilhelm, K. Scanlan, M. Stojak, P. Carlson-Kuhta, W. Liu, F. Horak, M. Mancini (Portland, USA)

    Objective: To evaluate the feasibility of adapting our Agility Boot Camp (ABC) for balance telerehabilitation (Tele-ABC) in people with mild-to-moderate Parkinson’s disease (PD). Background: Balance impairments…
  • 2024 International Congress

    Hand and Arm Function in Persons with De Novo Parkinson’s Disease

    B. Lindholm, LB. Dahlin, CH. Brogårdh, E. Franzen (Malmö, Sweden)

    Objective: To evaluate hand and arm function and its association with motor symptoms as well as activities of daily living (ADL) in de novo Parkinson's…
  • 2024 International Congress

    Does cannabis increase one’s risk for a fall in Parkinson’s disease?: cross-sectional analysis of self-report balance problems and freezing of gait

    M. Landers, A. Dockery, A. Hernandez, C. Miyashiro (Las Vegas, USA)

    Objective: To explore the effects of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) on self-report balance problems and freezing of gait (FOG) in Parkinson's disease (PD). Background:…
  • 2024 International Congress

    Perceptions of Diseases in Patients with Cervical Dystonia

    D. Talkington, D. Sblendorio, K. Pyle, M. Coleman, M. Patel, M. Moreno-Escobar, A. Murray, A. Memon, J. Frey (Morgantown, USA)

    Objective: To explore how perception of disease can impact stigma, mood, quality of life, and severity of symptoms in patients with cervical dystonia (CD). Background:…
  • 2024 International Congress

    ‘If you can’t beat them, join them’: a patient and family perspective on quality of life with North Sea progressive myoclonus epilepsy

    SS. Polet, MMG. Bracke, MAJ. Tijssen, TJ. de Koning (Groningen, Netherlands)

    Objective: To describe the perspectives of patients and their family on quality of life (QoL) in North Sea- Progressive Myoclonus Epilepsy (NS-PME). Background: NS-PME is…
  • 2024 International Congress

    Lumbar Punctures in Parkinson’s Research

    A. Navangul, H. Matthews, M. Bartlett, H. Groves, S. Stott, A. Noyce (London, United Kingdom)

    Objective: This study aims to explore patient perspectives on lumbar punctures for cerebrospinal fluid (CSF) analysis in Parkinson’s disease (PD) research, with the objective of…
  • 2024 International Congress

    Once-Daily Suvecaltamide Pharmacokinetics, Safety, & Tolerability–Phase 1, Randomized, Double-Blind, Multiple Ascending Dose Study

    S. Markova, M. Baladi, M. Lee, C. Chen (Palo Alto, USA)

    Objective: Evaluate the pharmacokinetics (PK), safety, and tolerability of a once-daily (QD) suvecaltamide (JZP385) formulation and its major active metabolites (JZZ05000034=M01, JZZ05000035=M02) in a Phase…
  • « Previous Page
  • 1
  • …
  • 127
  • 128
  • 129
  • 130
  • 131
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley